Olivier Brandicourt
CIK: 0001508518
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 15, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct2.2K shares- - Jun 11, 2026ONC
BeOne Medicines Ltd.
Award(A)Direct19K shares- - May 20, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
Award(A)Direct671 shares- - Jan 15, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct1.4K shares- - Jun 12, 2025PCVX
Vaxcyte, Inc.
Award(A)Direct1.1K shares- - May 21, 2025BGNE
BeiGene, Ltd.
Award(A)Direct11K shares- - May 8, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
Award(A)Direct775 shares- - May 1, 2025PCVX
Vaxcyte, Inc.
Award(A)DirectStock Option (right to buy)
40.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  PCVX Vaxcyte, Inc. | Award(A) | 2,194 | - | $0 | Direct |
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award(A) | 18,980 | - | $0 | Direct |
| May 20, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Award(A) | 671 | - | $0 | Direct |
| Jan 15, 2026 | PCVX Vaxcyte, Inc. | Award(A) | 1,357 | - | $0 | Direct |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | Award(A) | 1,148 | - | - | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award(A) | 10,985 | - | - | Direct |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Award(A) | 775 | - | - | Direct |
| May 1, 2025 | PCVX Vaxcyte, Inc. | Award(A) Stock Option (right to buy) | 40,113 | - | - | Direct |
1-8 of 8 transactions
About BRANDICOURT OLIVIER
BRANDICOURT OLIVIER (SEC CIK 0001508518) files insider reports with the SEC as Director of Vaxcyte, Inc. (PCVX), Director of BeOne Medicines Ltd. (ONC) and Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY).
Signal8 holds 9 ownership filings by BRANDICOURT OLIVIER (1 Form 3, 8 Form 4), filed between May 2, 2025 and Jun 16, 2026. Those filings report 8 transactions, from May 1, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BRANDICOURT OLIVIER's filings is in BASEL.
Recent filings by BRANDICOURT OLIVIER
- Jun 15, 2026: Grant or award of PCVX shares (Form 4, code A).
- Jun 11, 2026: Grant or award of ONC shares (Form 4, code A).
- May 20, 2026: Grant or award of ALNY shares (Form 4, code A).
- Jan 15, 2026: Grant or award of PCVX shares (Form 4, code A).
- Jun 12, 2025: Grant or award of PCVX shares (Form 4, code A).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer